RESUMO
Hyperpolarized (HP) gases are a new class of contrast agents that permit to obtain high temporal and spatial resolution magnetic resonance images (MRI) of the lung airspaces. HP gas MRI has become important research tool not only for morphological and functional evaluation of normal pulmonary physiology but also for regional quantification of pathologic changes occurring in several lung diseases. The purpose of this work is to provide an introduction to MRI using HP noble gases, describing both the basic principles of the technique and the new information about lung disease provided by clinical studies with this method. The applications of the technique in normal subjects, smoking related lung disease, asthma, and cystic fibrosis are reviewed.
Assuntos
Meios de Contraste , Hélio , Pneumopatias/diagnóstico por imagem , Imageamento por Ressonância Magnética/métodos , Xenônio , HumanosRESUMO
Infant acute lymphoblastic leukemia (IALL) is characterized by mixed lineage leukemia (MLL) gene rearrangements, unique gene expression profiles, poor prognosis, and drug resistance. One exception is cytosine arabinoside (Ara-C) to which IALL cells seem to be more sensitive. We quantified mRNA expression of Ara-C key enzymes in leukemic lymphoblasts from 64 Brazilian ALL children, 15 of them presenting MLL gene rearrangement, and correlated it with clinical and biological features. The diagnosis was based on morphological criteria and immunophenotyping using monoclonal antibodies. MLL gene rearrangements were detected by conventional cytogenetic analysis, RT-PCR and/or fluorescence in situ hybridization. The DCK and HENT1 expression levels were determined by real-time quantitative PCR using SYBR Green I. Relative quantification was made by the standard curve method. The results were analyzed by Mann-Whitney and Fisher exact tests. A P value of Assuntos
Antimetabólitos Antineoplásicos/metabolismo
, Citarabina/metabolismo
, Rearranjo Gênico/genética
, Proteína de Leucina Linfoide-Mieloide/genética
, Leucemia-Linfoma Linfoblástico de Células Precursoras/genética
, Antimetabólitos Antineoplásicos/uso terapêutico
, Estudos de Casos e Controles
, Criança
, Pré-Escolar
, Citarabina/uso terapêutico
, Desoxicitidina Quinase/efeitos dos fármacos
, Desoxicitidina Quinase/genética
, Transportador Equilibrativo 1 de Nucleosídeo/efeitos dos fármacos
, Transportador Equilibrativo 1 de Nucleosídeo/genética
, Feminino
, Regulação Neoplásica da Expressão Gênica
, Humanos
, Lactente
, Masculino
, Proteína de Leucina Linfoide-Mieloide/efeitos dos fármacos
, Neoplasia Residual
, Reação em Cadeia da Polimerase/métodos
, Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico
, Leucemia-Linfoma Linfoblástico de Células Precursoras/enzimologia
, RNA Mensageiro/análise
, Fatores de Tempo
RESUMO
BACKGROUND: In patients with acute myocardial infarction (MI), delayed enhancement is seen in MRI 5 to 7 minutes after gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) injection, and the enhancement occurs in regions that later show recovery of function. However, in a canine model of acute MI, delayed enhancement 20 to 30 minutes after injection only occurs in necrotic regions and not in surrounding, reversibly injured myocardium. The objective of the present study was to determine (1) if the size of the enhanced region varies with time after Gd-DTPA injection and (2) if and when the size of the enhanced region corresponds to the true infarct size. METHODS AND RESULTS: The left coronary artery was occluded in 15 Lewis rats for 30 minutes (n=9) or 2 hours (n=6); this was followed by reperfusion. MRI scans were performed 48+/-2 hours after-MI. Midventricular short-axis images were obtained continuously for 40 minutes after Gd-DTPA injection (0.3 mmol/kg). The sizes of enhanced regions at each time were determined by threshold analysis and compared with triphenyltetrazolium chloride-stained sections of the excised rat heart. In all animals, the enhanced region overestimated infarct size (28+/-5%) immediately after the injection of Gd-DTPA, although it then gradually receded to match the size of the infarct. The time required for enhancement to accurately determine infarct size was significantly different between 2-hour infarcts (16+/-2 minutes) and 30-minute (26+/-4 minutes) infarcts (P<0.05). CONCLUSIONS: In reperfused acute MI, accurate determination of infarct size by delayed enhancement MRI requires imaging at specific times after Gd-DTPA injection, and this time varies with the duration of occlusion.
Assuntos
Imageamento por Ressonância Magnética/métodos , Infarto do Miocárdio/patologia , Animais , Meios de Contraste , Gadolínio DTPA , Aumento da Imagem , Infarto do Miocárdio/etiologia , Reperfusão Miocárdica/efeitos adversos , Ratos , Ratos Endogâmicos Lew , Fatores de TempoRESUMO
The concentrative pyrimidine-preferring nucleoside transporter 1 (hCNT1), cloned from human fetal liver, was expressed in Xenopus laevis oocytes. Using the two-electrode voltage-clamp technique, it is shown that translocation of nucleosides by this transporter generates sodium inward currents. Membrane hyperpolarization (from -50 to -150 mV) did not affect the K(0.5) for uridine, although it increased the transport current approximately 3-fold. Gemcitabine (a pyrimidine nucleoside-derived drug) but not fludarabine (a purine nucleoside-derived drug) induced currents in oocytes expressing the hCNT1 transporter. The K(0.5) value for gemcitabine at -50 mV membrane potential was lower than that for natural substrates, although this drug induced a lower current than uridine and cytidine, thus suggesting that the affinity binding of the drug transporter is high but that translocation occurs more slowly. The analysis of the currents generated by the hCNT1-mediated transport of nucleoside-derived drugs used in anticancer and antiviral therapies will be useful in the characterization of the pharmacological profile of this family of drug transporters and will allow rapid screening for uptake of newly developed nucleoside-derived drugs.
Assuntos
Antineoplásicos/metabolismo , Proteínas de Transporte/metabolismo , Desoxicitidina/análogos & derivados , Proteínas de Membrana/metabolismo , Nucleosídeos/metabolismo , Vidarabina/análogos & derivados , Animais , Antimetabólitos Antineoplásicos/metabolismo , Antivirais/metabolismo , Proteínas de Transporte/genética , Citidina/metabolismo , Desoxicitidina/metabolismo , Condutividade Elétrica , Expressão Gênica , Humanos , Potenciais da Membrana , Proteínas de Membrana/genética , Proteínas de Transporte de Nucleosídeos , Oócitos/metabolismo , Sódio/metabolismo , Especificidade por Substrato , Uridina/metabolismo , Vidarabina/metabolismo , Xenopus laevis , GencitabinaRESUMO
A new technique is demonstrated in six healthy human subjects that combines grid-tagging and hyperpolarized helium-3 MRI to assess regional lung biomechanical function and quantitative ventilation. 2D grid-tagging, achieved by applying sinc-modulated RF-pulse trains along the frequency- and phase-encoding directions, was followed by a multislice fast low-angle shot (FLASH)-based acquisition at inspiration and expiration. The displacement vectors, first and second principal strains, and quantitative ventilation were computed, and mean values were calculated for the upper, middle, and lower lung regions. Displacements in the lower region were significantly greater than those in either the middle or upper region (P < 0.005), while there were no significant differences between the three regions for the two principal strains and quantitative ventilation (P = 0.11-0.92). Variations in principal strains and ventilation were greater between subjects than between lung zones within individual subjects. This technique has the potential to provide insight into regional biomechanical alterations of lung function in a variety of lung diseases.
Assuntos
Hélio , Imageamento por Ressonância Magnética/métodos , Ventilação Pulmonar/fisiologia , Adulto , Algoritmos , Fenômenos Biomecânicos , Feminino , Humanos , Isótopos , Masculino , Testes de Função Respiratória , Mecânica RespiratóriaRESUMO
The records and biopsies of 10 patients with the diagnosis of leiomyosarcomas admitted at the Military Hospital "Dr. Carlos Arvelo" from 1962 to 1991, were reviewed. The sample correspond to 0.47% of all gastro-intestinal tumors. Sixty per cent of tumors were localized in the stomach, 20% in the jejunum, 10% in the duodenum and 10% in the colon. Eighty per cent had pain and 60% had bleeding. Sixty per cent of tumors were low grade leiomyosarcomas and 40% were epithelioid leiomyosarcomas. In eight of nine patients operated, resection was done. The survival range was from six months to 28 years with a median of 12 years. The most important prognostic factor was the extension of the tumor, independently of he histologic type.
Assuntos
Neoplasias Gastrointestinais/patologia , Leiomiossarcoma/patologia , Adulto , Fatores Etários , Idoso , Feminino , Neoplasias Gastrointestinais/mortalidade , Neoplasias Gastrointestinais/cirurgia , Humanos , Leiomiossarcoma/mortalidade , Leiomiossarcoma/cirurgia , Masculino , Pessoa de Meia-Idade , Prognóstico , Fatores Sexuais , Taxa de SobrevidaRESUMO
A cDNA of 3.2 kb, encoding a putative G protein-coupled receptor and hence called bRGR1, has been isolated from a cDNA library generated from the bovine renal epithelial cell line NBL-1. This cDNA consisted of 41 base pairs of 5'-untranslated sequence, an open reading frame of 1083 base pairs, and a 2.07 kb fragment of 3'-untranslated sequence that includes a poly(dA) tail. The coding sequence predicts a protein of 361 residues. The ligand of the bRGR1 protein may be of low molecular weight, as deduced from the analysis of the predicted primary structure of the receptor protein and the comparison with other subtypes of the G protein-coupled receptor family. The amounts of bRGR1 mRNA significantly increase when NBL-1 cells are cultured in an amino acid-depleted medium. This effect can not be caused by a decrease in protein synthesis because cycloheximide did not mimic the increase in bRGR1 mRNA levels triggered by amino acid starvation. These data suggest that bRGR1 may be an amino acid-regulated gene.
Assuntos
Aminoácidos/fisiologia , Regulação da Expressão Gênica , Rim/metabolismo , RNA Mensageiro/metabolismo , Receptores de Superfície Celular/genética , Receptores Acoplados a Proteínas G , Sequência de Aminoácidos , Animais , Sequência de Bases , Bovinos , Linhagem Celular , Clonagem Molecular/métodos , DNA Complementar/isolamento & purificação , Epitélio , Dados de Sequência Molecular , Receptores de Superfície Celular/biossínteseRESUMO
Nucleoside transport systems and their regulation in human B-lymphocytes have been characterized using the cell lines Raji and Bare lymphoma syndrome-1 (BLS-1) as experimental models. These cells express at least three different nucleoside transport systems as follows: a nitrobenzylthioinosine-sensitive equilibrative transport system of the es-type, which appears to be associated with hENT1 expression, and two Na+-dependent transport systems that may correspond to N1 and to the recently characterized N5-type, which is nitrobenzylthioinosine-sensitive and guanosine-preferring. B cell activators such as phorbol 12-myristate 13-acetate and lipopolysaccharide (LPS) up-regulate both concentrative transport systems but down-regulate the equilibrative es-type transporter, which correlates with lower hENT1 mRNA levels. These effects are dependent on protein kinase C activity. Phorbol 12-myristate 13-acetate and LPS also induce an increase in tumor necrosis factor-alpha (TNF-alpha) mRNA levels, which suggest that this cytokine may mediate some of the effects triggered by these agents, since addition of TNF-alpha alone can increase N1 and N5 transport activities by a mechanism that also depends on protein kinase C activation. Interestingly, TNF-alpha down-regulates es activity, but this effect cannot be abolished by inhibiting protein kinase C. This study reveals differential regulation of nucleoside transport systems following activation of human B-lymphocyte cell lines by agents of physiological relevance such as TNF-alpha and LPS. Moreover, it indicates that the recently characterized N5 transport system can also be regulated following B cell activation, which may be relevant to lymphocyte physiology and to the treatment of lymphocyte malignancies.
Assuntos
Linfócitos B/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Nucleosídeos/metabolismo , Acetato de Tetradecanoilforbol/farmacologia , Fator de Necrose Tumoral alfa/farmacologia , Linfócitos B/metabolismo , Sequência de Bases , Transporte Biológico , Primers do DNA , Humanos , Proteína Quinase C/metabolismo , Células Tumorais CultivadasRESUMO
We present a 15-years-old female patient severely malnourished due to complications of abdominal surgery, who received total parenteral nutrition during 118 days. The clinical and laboratory parameters are analyzed and a photographic sequence is presented. During the treatment period nitrogen balance was positive and her weight increased in 50%.
Assuntos
Distúrbios Nutricionais/terapia , Nutrição Parenteral Total , Complicações Pós-Operatórias/terapia , Procedimentos Cirúrgicos Operatórios , Doença Aguda , Adolescente , Terapia Combinada , Feminino , Humanos , Distúrbios Nutricionais/diagnóstico , Complicações Pós-Operatórias/diagnóstico , Fatores de TempoRESUMO
Liver parenchymal cells show a wide variety of plasma membrane transporters that are tightly regulated by endocrine and nutritional factors. This review summarizes work performed in our laboratory on these transport systems, particularly nucleoside transporters, which are up-regulated in physiological situations associated with liver cell growth. Rat hepatocytes show a Na+-dependent nucleoside transport activity that is stimulated by pancreatic hormones. Indeed, this biological activity appears to be the result of the co-expression of at least two isoforms of nucleoside carriers, CNT1 and CNT2 (also called SPNT). These two transporters are up-regulated during the early phase of liver growth after partial hepatectomy, although to different extents, suggesting differential regulation of the two isoforms. The recent generation of isoform-specific antibodies allowed us to demonstrate that carrier expression may also have complex post-transcriptional regulation on the basis of the lack of correspondence between mRNA and protein levels. The analysis of nucleoside transport systems in hepatoma cells and the comparison with those in hepatocytes has also provided evidence that the differentiation status of liver parenchymal cells may determine the pattern of nucleoside transporters expressed.
Assuntos
Proteínas de Transporte/fisiologia , Fígado/crescimento & desenvolvimento , Nucleosídeos/fisiologia , Animais , Carcinoma Hepatocelular/metabolismo , Humanos , Cinética , Masculino , Ratos , Ratos Wistar , Células Tumorais CultivadasRESUMO
Hyperpolarized gas MR virtual colonography was performed in plastic phantoms and in the dog colon. (3)He was laser polarized in a prototype commercial system. 2D and 3D gradient echo sequences were used to image the noble gas-filled structures. The hyperpolarized (3)He within the plastic tube and colon lumen produced high signal, providing excellent contrast from the surrounding structures. The virtual colonoscopic analysis of the canine dataset allowed visualization of the colonic features and the colonic wall from inside the colon. (3)He colonoscopy is a novel technique to visualize the colon with MRI with the application of an inert gaseous endoluminal contrast agent.
Assuntos
Colo/anatomia & histologia , Meios de Contraste/metabolismo , Hélio/metabolismo , Imageamento por Ressonância Magnética/métodos , Animais , Neoplasias do Colo/diagnóstico , Cães , Estudos de ViabilidadeRESUMO
We attempt to identify the plasma membrane transporter involved in the uptake of 5'-deoxy-5-fluorouridine (5'-DFUR), an intermediate metabolite of capecitabine. This novel oral fluoropyrimidine is used in cancer treatments and is a direct precursor of the cytostatic agent 5'-fluorouracil. We also examine the role of the transporter in 5'-DFUR cytotoxicity. The human concentrative nucleoside transporter (hCNT1) was cloned from human fetal liver and expressed in Xenopus laevis oocytes. The two-electrode voltage-clamp technique was used to demonstrate that 5'-DFUR, but not capecitabine or 5'-FU, is an hCNT1 substrate. Then, hCNT1 was heterologously expressed in the mammalian cell line Chinese hamster ovary-K1. Functional expression was demonstrated by monitoring transport of radiolabeled substrates and by using a monospecific polyclonal antibody generated against the transporter. hCNT1-expressing cells were more sensitive to 5'-DFUR than vector-transfected or wild-type cells. The sensitivity of the three cell types to other agents such as cisplatin or 5'-FU was identical. In conclusion, this study shows that 1) the pharmacological profile of a nucleoside transporter can be determined by an electrophysiological approach; 2) the hCNT1 transporter is involved in 5'-DFUR uptake; and 3) hCNT1 expression may increase cell sensitivity to 5'-DFUR treatment. This study also reports for the first time the generation of an antibody against hCNT1, which may be useful in the elucidation of the relationship between hCNT1 expression and tumor response to capecitabine treatment.
Assuntos
Antimetabólitos Antineoplásicos/farmacologia , Proteínas de Transporte/metabolismo , Desoxicitidina/farmacologia , Floxuridina/farmacologia , Proteínas de Membrana Transportadoras , Pró-Fármacos/farmacologia , Administração Oral , Animais , Antimetabólitos Antineoplásicos/metabolismo , Células CHO , Capecitabina , Sobrevivência Celular/efeitos dos fármacos , Clonagem Molecular , Cricetinae , DNA Complementar/análise , Desoxicitidina/análogos & derivados , Desoxicitidina/metabolismo , Ensaios de Seleção de Medicamentos Antitumorais , Feto/fisiologia , Fluoruracila/análogos & derivados , Humanos , Fígado/fisiologia , Oócitos/metabolismo , Pró-Fármacos/metabolismo , Transfecção , Xenopus laevisRESUMO
Infant acute lymphoblastic leukemia (IALL) is characterized by mixed lineage leukemia (MLL) gene rearrangements, unique gene expression profiles, poor prognosis, and drug resistance. One exception is cytosine arabinoside (Ara-C) to which IALL cells seem to be more sensitive. We quantified mRNA expression of Ara-C key enzymes in leukemic lymphoblasts from 64 Brazilian ALL children, 15 of them presenting MLL gene rearrangement, and correlated it with clinical and biological features. The diagnosis was based on morphological criteria and immunophenotyping using monoclonal antibodies. MLL gene rearrangements were detected by conventional cytogenetic analysis, RT-PCR and/or fluorescence in situ hybridization. The DCK and HENT1 expression levels were determined by real-time quantitative PCR using SYBR Green I. Relative quantification was made by the standard curve method. The results were analyzed by Mann-Whitney and Fisher exact tests. A P value of ú0.05 was considered to be statistically significant. DCK and HENT1 expression levels were significantly lower in children with MLL gene-rearranged ALL compared to children with MLL germ line ALL (P = 0.0003 and 0.03, respectively). Our results differ from previous ones concerning HENT1 mRNA expression that observed a higher expression level in MLL gene-rearranged leukemias. In conclusion, the expression of the genes related to Ara-C metabolism was lower in MLL-positive children in the sample studied, suggesting the presence of population differences in the expression profile of these genes especially for HENT1.